Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03327922 · ClinicalTrials.gov registry record · NA
Interrupted Subdermal Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis
A NA study of Interrupted Subdermal Suture, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03327922 is a NA study of Interrupted Subdermal Suture that has completed, run by University of California, Davis. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03327922, a NA study of Interrupted Subdermal Suture, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to investigate whether the spacing of the interrupted deep (subdermal) sutures affects surgical wound cosmesis on the trunk and extremities. In other words, the investigator would like to determine which of the following yields a more cosmetically appealing scar: many closely approximated subdermal sutures or fewer, more widely spaced subdermal sutures. The investigator wishes to compare the effects of one versus two centimeter spacing between sutures.
Conditions Studied
Interventions
- DEVICE Vicryl absorbable suture
Study Locations (1)
California
- University of California, Davis, Department of Dermatology - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2022-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03327922
The ClinicalTrials.gov registry entry for NCT03327922 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Interrupted Subdermal Suture appearing as the primary indexed condition, and to 1 intervention - of which Vicryl absorbable suture is the first listed.
NCT03327922 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03327922 about?
NCT03327922 is a clinical study titled "Interrupted Subdermal Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis". This study aims to investigate whether the spacing of the interrupted deep (subdermal) sutures affects surgical wound cosmesis on the trunk and extremities. In other words, the investigator would like to determine which of the following yields a more cosmetically appealing scar: many closely approxi...
What is the current status of trial NCT03327922?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-09-20. Estimated completion is 2022-03-02.
What conditions does trial NCT03327922 study?
This clinical trial studies the following conditions: Interrupted Subdermal Suture.
What interventions are being tested in trial NCT03327922?
The interventions under investigation include: Vicryl absorbable suture (DEVICE).
Who is sponsoring clinical trial NCT03327922?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03327922 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.